Login Register Cart 0
Generic placeholder image

Current Stem Cell Research & Therapy

Editor-in-Chief

ISSN (Print): 1574-888X
ISSN (Online): 2212-3946

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Advances in Stem Cell Therapy for Intestinal Diseases: Mechanisms, Perspectives Regarding Clinical Applications, and Challenges

Author(s): Weiwen Fan, Le Chang, Xinghua Pan and Xiangqing Zhu*

Volume 18, Issue 4, 2023

Published on: 07 September, 2022

Page: [499 - 512] Pages: 14

DOI: 10.2174/1574888X17666220629094253

Price: $65

Abstract

Background: Intestinal disease is a common disease, which can cause serious digestion and absorption disorders, endanger the lives of patients and seriously affect the quality of life of people. Finding an effective treatment is a difficult problem at present, and stem cell therapy as a treatment has high application potential in intestinal-related diseases.

Purpose: This paper mainly summarizes the mechanism, research progress and future development trend of stem cells in the treatment of intestinal diseases in the past decade, hoping to provide a reference for future researchers in the research and application of stem cells and intestinal diseases.

Methods: Stem cells, inflammatory bowel diseases, Crohn's disease, radiation-induced intestinal injury, radiation enterocolitis, and extracellular vesicles were used as search terms. Relevant references in the past ten years were searched in CNKI journal full-text database, PubMed database, VIP network and Wanfang medical network, and 80 literature studies meeting the requirements were finally included for review.

Results: This paper summarizes the research and application of stem cells in intestinal diseases from 2012 to 2021, and expounds on the specific mechanism of stem cells in the treatment of intestinal diseases. It has been found that stem cells can treat intestinal injury or inflammation in different ways.

Conclusion: Future stem cells may also be used to reverse the natural aging of intestinal function, improve intestinal function, and strengthen gastrointestinal function.

Keywords: Stem cells, mesenchymal stem cells, intestine, radiation enteritis, inflammatory bowel disease, digestion.

« Previous Next »
[1]
Rao VL, Micic D, Kim KE. Primary care evaluation and management of gastroenterologic issues in women. Obstet Gynecol Clin North Am 2016; 43(2): 347-66.
[http://dx.doi.org/10.1016/j.ogc.2016.01.006] [PMID: 27212096]
[2]
Ning L, Jin S, Ning NY. Research progress of treatment of inflammatory bowel disease by genetically engineered mesenchymal stem cell transplantation. International Journal of J Digestive Diseases 2021; 41(3): 4. [https://doi.org/10.3969/j.issn.1673-534X.2021.03.002
[3]
Oronsky B, Reid T, Larson C, Knox SJ. Locally advanced rectal cancer: The past, present, and future. Semin Oncol 2020; 47(1): 85-92.
[http://dx.doi.org/10.1053/j.seminoncol.2020.02.001] [PMID: 32147127]
[4]
Li Q. Liujiankun, Panxinghua. Stem cell transplantation for inflammatory bowel disease. Chinese Journal of Tissue Engineering Research 2017; 21(021): 3432-7.
[http://dx.doi.org/10.3969/j.issn.2095-4344.2017.21.025]
[5]
Zhang Y. A meta analysis of the clinical efficacy and safety of mesenchymal stem cells in the treatment of inflammatory bowel disease 2020.
[http://dx.doi.org/10.27258/d.cnki.gnxyc.2020.000360]
[6]
Nebert DW, Liu Z. SLC39A8 gene encoding a metal ion transporter: discovery and bench to bedside. Hum Genomics 2019; 13(S1) (Suppl. 1): 51.
[http://dx.doi.org/10.1186/s40246-019-0233-3] [PMID: 31521203]
[7]
Kun YL, Shao YP. Chih Jen Chou, Herng Sheng Lee, Shinn Chih Wu Infusion of Porcine-Derived Amniotic Fluid Stem Cells for Treatment of Experimental Colitis in Mice Chin J Physiol 2017; 60(6)
[http://dx.doi.org/10.4077/CJP.2017.BAG509.]
[8]
Shroff G. Human Embryonic Stem Cell Therapy in Crohn’s Disease: A Case Report. Am J Case Rep 2016; 17: 124-8.
[http://dx.doi.org/10.12659/AJCR.896512] [PMID: 26923312]
[9]
Srivastava AS, Feng Z, Mishra R, Malhotra R, Kim HS, Carrier E. Embryonic stem cells ameliorate piroxicam-induced colitis in IL10-/- KO mice. Biochem Biophys Res Commun 2007; 361(4): 953-9.
[http://dx.doi.org/10.1016/j.bbrc.2007.07.139] [PMID: 17692287]
[10]
Li J, He J, Lin G, Lu G. Inducing human parthenogenetic embryonic stem cells into islet-like clusters. Molecular Medicine Reports 2014; 10(6): 2882-90.
[http://dx.doi.org/10.3892/mmr.2014.2588]
[11]
Qing-yang meng Directed differentiation of human parthenogenetic embryonic stem cells intointestinal epithelial stem cells Kunming University of Science and Technology. KUST 2019.
[http://dx.doi.org/10.27200/d.cnki.gkmlu.2019.000627]
[12]
Meng Q, Wang Z. Dragon Chen, Liang Rui. Research progress of stem cells in the treatment of inflammatory bowel disease. Chemistry of life 2019; (2): 5.
[http://dx.doi.org/10.13488/j.smhx.20181314.]
[13]
Jones E, McGonagle D. Human bone marrow mesenchymal stem cells in vivo. Rheumatology (Oxford) 2008; 47(2): 126-31.
[http://dx.doi.org/10.1093/rheumatology/kem206] [PMID: 17986482]
[14]
Saha S, Bhanja P, Kabarriti R, Liu L, Alfieri AA, Guha C. Bone marrow stromal cell transplantation mitigates radiation-induced gastrointestinal syndrome in mice. PLoS One 2011; 6(9)e24072
[http://dx.doi.org/10.1371/journal.pone.0024072] [PMID: 21935373]
[15]
Ma F, Sha W, Wang Q, Li J, Quan L, Luo Y. Inflammation activated bone marrow mesenchymal stem cell conditioned medium repairs radiation-induced acute injury to intestinal epithelial stem cells Chinese Journal of Tissue Engineering Research 2019; 23(9): 1324-9.
[http://dx.doi.org/10.3969/j.issn.2095-4344.1602]
[16]
Sémont A, Sabine Franois M. Mesenchymal stem cells increase self-renewal of small intestinal epithelium and accelerate structural recovery after radiation injury.In: Fisher, JP (eds) Tissue Engineering Advances in Experimental Medicine and Biology, Vol 585, Springer, Boston.
[http://dx.doi.org/10.1007/978-0-387-34133-0_2]
[17]
Jing Z, Song H. Research progress of bone marrow mesenchymal stem cells in the treatment of intestinal diseases Journal of Tianjin Medical University 2011; (4): 571-3.
[http://dx.doi.org/10.3969/j.issn.1006-8147.2011.04.045]
[18]
Qiu H, Liu F, Jie L. etc Effect of bone marrow mesenchymal stem cells transplantation in reconstructing hematopoiesis function of mice with critical irradiation injury Journal of Second Military Medical University 2008; 29(9): 1015.
[http://dx.doi.org/10.3321/j.issn:0258-879X.2008.09.002]
[19]
Okamoto R, Shimizu H, Suzuki K, et al. Organoid-based regenerative medicine for inflammatory bowel disease. Regen Ther 2020; 13: 1-6.
[http://dx.doi.org/10.1016/j.reth.2019.11.004] [PMID: 31970266]
[20]
Zheng K, Wu W, Yang S, et al. Treatment of radiation-induced acute intestinal injury with bone marrow-derived mesenchymal stem cells. Exp Ther Med 2016; 11(6): 2425-31.
[http://dx.doi.org/10.3892/etm.2016.3248] [PMID: 27284330]
[21]
Linard C, Busson E, Holler V, et al. Repeated autologous bone marrow-derived mesenchymal stem cell injections improve radiation-induced proctitis in pigs. Stem Cells Transl Med 2013; 2(11): 916-27.
[http://dx.doi.org/10.5966/sctm.2013-0030] [PMID: 24068742]
[22]
Hayashi Y, Tsuji S, Tsujii M, et al. Topical implantation of mesenchymal stem cells has beneficial effects on healing of experimental colitis in rats. J Pharmacol Exp Ther 2008; 326(2): 523-31.
[http://dx.doi.org/10.1124/jpet.108.137083] [PMID: 18448866]
[23]
Chang P, Qu Y, Liu Y, et al. Multi-therapeutic effects of human adipose-derived mesenchymal stem cells on radiation-induced intestinal injury. Cell Death Dis 2013; 4(6)e685
[http://dx.doi.org/10.1038/cddis.2013.178] [PMID: 23788042]
[24]
Németh K, Leelahavanichkul A, Yuen PS, et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 2009; 15(1): 42-9.
[http://dx.doi.org/10.1038/nm.1905] [PMID: 19098906]
[25]
Song WJ, Li Q, Ryu MO, et al. TSG-6 Secreted by Human Adipose Tissue-derived Mesenchymal Stem Cells Ameliorates DSS-induced colitis by Inducing M2 Macrophage Polarization in Mice. Sci Rep 2017; 7(1): 5187.
[http://dx.doi.org/10.1038/s41598-017-04766-7] [PMID: 28701721]
[26]
Gonzalez R, Garitaonandia I, Crain A, et al. Proof of concept studies exploring the safety and functional activity of human parthenogenetic-derived neural stem cells for the treatment of Parkinson’s disease. Cell Transplant 2015; 24(4): 681-90.
[http://dx.doi.org/10.3727/096368915X687769] [PMID: 25839189]
[27]
Fan CG, Zhang QJ, Zhou JR. Therapeutic potentials of mesenchymal stem cells derived from human umbilical cord. Stem Cell Rev Rep 2011; 7(1): 195-207.
[http://dx.doi.org/10.1007/s12015-010-9168-8] [PMID: 20676943]
[28]
Jing L, Han D, Mei X, et al. Umbilical cord mesenchymal stem cell infusion for refractory ulcerative colitis. Journal of Tissue Engineering and Reconstruction Surgery 2011; 07(5): 258-60.
[29]
Gao Z, Zhang Q, Han Y, et al. Mesenchymal stromal cell-conditioned medium prevents radiation-induced small intestine injury in mice. Cytotherapy 2012; 14(3): 267-73.
[http://dx.doi.org/10.3109/14653249.2011.616194] [PMID: 21958222]
[30]
Wang R, Yuan W, Zhao Q, et al. An experimental study of preventing and treating acute radioactive enteritis with human umbilical cord mesenchymal stem cells. Asian Pac J Trop Med 2013; 6(12): 968-71.
[http://dx.doi.org/10.1016/S1995-7645(13)60173-X] [PMID: 24144029]
[31]
Hu J, Zhao G, Zhang L, et al. Safety and therapeutic effect of mesenchymal stem cell infusion on moderate to severe ulcerative colitis. Exp Ther Med 2016; 12(5): 2983-9.
[http://dx.doi.org/10.3892/etm.2016.3724] [PMID: 27882104]
[32]
Spijkerman R, Hesselink L, Bertinetto C, et al. Refractory neutrophils and monocytes in patients with inflammatory bowel disease after repeated bouts of prolonged exercise. Cytometry B Clin Cytom 2021; 100(6): 676-82.
[http://dx.doi.org/10.1002/cyto.b.21996] [PMID: 33683008]
[33]
Wang G, Mdm Joel J. Human umbilical cord mesenchymal stem cells alleviate inflammatory bowel disease by inhibiting ERK phosphorylation in neutrophils. Inflammopharmacology 2020; 28(2): 603-16.
[http://dx.doi.org/10.1007/s10787-019-00683-5] [PMID: 31938969]
[34]
Lin Y, Lin L, Wang Q, et al. Transplantation of human umbilical mesenchymal stem cells attenuates dextran sulfate sodium-induced colitis in mice. Clin Exp Pharmacol Physiol 2015; 42(1): 76-86.
[http://dx.doi.org/10.1111/1440-1681.12321] [PMID: 25311720]
[35]
Banerjee A, Bizzaro D, Burra P, et al. Umbilical cord mesenchymal stem cells modulate dextran sulfate sodium induced acute colitis in immunodeficient mice. Stem Cell Res Ther 2015; 6(1): 79.
[http://dx.doi.org/10.1186/s13287-015-0073-6] [PMID: 25890182]
[36]
Hua G, Thin TH, Feldman R, et al. Crypt base columnar stem cells in small intestines of mice are radioresistant. Gastroenterology 2012; 143(5): 1266-76.
[http://dx.doi.org/10.1053/j.gastro.2012.07.106] [PMID: 22841781]
[37]
Gavazzi C, Bhoori S, Lovullo S, Cozzi G, Mariani L. Role of home parenteral nutrition in chronic radiation enteritis. Am J Gastroenterol 2006; 101(2): 374-9.
[http://dx.doi.org/10.1111/j.1572-0241.2006.00438.x] [PMID: 16454846]
[38]
Wang Y, Meng A, Lang H, et al. Activation of nuclear factor kappaB In vivo selectively protects the murine small intestine against ionizing radiation-induced damage. Cancer Res 2004; 64(17): 6240-6.
[http://dx.doi.org/10.1158/0008-5472.CAN-04-0591] [PMID: 15342410]
[39]
Shaker A, Rubin DC. Stem cells: One step closer to gut repair. Nature 2012; 485(7397): 181-2.
[http://dx.doi.org/10.1038/485181a] [PMID: 22575955]
[40]
Fukuda M, Mizutani T, Mochizuki W, et al. Small intestinal stem cell identity is maintained with functional Paneth cells in heterotopically grafted epithelium onto the colon. Genes and Development 2014; 28(16): 1752-7.
[41]
Cassinotti A, Annaloro C, Ardizzone S, et al. Autologous haematopoietic stem cell transplantation without CD34+ cell selection in refractory Crohn’s disease. Gut 2008; 57(2): 211-7.
[http://dx.doi.org/10.1136/gut.2007.128694] [PMID: 17895357]
[42]
Daniel W. Hommes, Duijvestein Marjolijn, Zelinkova Zuzana, Pieter C. F. Stokkers, Ley Maartje Holsbergen-De, Stoker Jaap, Voermans Carlijn, Oers Marinus H. J. Van, Kersten Marie José. Long-term follow-up of autologous hematopoietic stem cell transplantation for severe refractory Crohn’s disease. J Crohn’s Colitis 2011; 5(6): 543-9.
[http://dx.doi.org/10.1016/j.crohns.2011.05.004]
[43]
Snowden JA, Saccardi R, Allez M, et al. Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 2012; 47(6): 770-90.
[http://dx.doi.org/10.1038/bmt.2011.185] [PMID: 22002489]
[44]
Cui G, Liu X. Study Progress of the Treatment of Inflammatory Bowel Disease by Bone Marrow Mesenchymal Stem Cells. Pharmacy Today 2019; 29(01): 857-60.
[http://dx.doi.org/10.12048/j.issn.1674-229X.2019.01.017.]
[45]
Yang H, Feng R, Fu Q, et al. Human induced pluripotent stem cell-derived mesenchymal stem cells promote healing via TNF-α-stimulated gene-6 in inflammatory bowel disease models. Cell Death Dis 2019; 10(10): 718.
[http://dx.doi.org/10.1038/s41419-019-1957-7] [PMID: 31558705]
[46]
Théry C, Witwer KW, Aikawa E, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles 2018; 7(1)1535750
[http://dx.doi.org/10.1080/20013078.2018.1535750] [PMID: 30637094]
[47]
Fais S, O’Driscoll L, Borras FE, et al. A Cordeiro da Silva, H Del Portillo, S El Andaloussi, T. Ficko Trček, Furlan, R, A Hendrix, I Gursel, V Kralj-Iglic, B Kaeffer, M Kosanovic, M. E Lekka, G Lipps, M Logozzi. Evidence-Based Clinical Use of Nanoscale Extracellular Vesicles in Nanomedicine. ACS Nano 2016; 10(4): 3886.
[http://dx.doi.org/10.1021/acsnano.5b08015] [PMID: 26978483]
[48]
Harrell CR, Fellabaum C, Jovicic N, Djonov V, Arsenijevic N, Volarevic V. Molecular Mechanisms Responsible for Therapeutic Potential of Mesenchymal Stem Cell-Derived Secretome. Cells 2019; 8(5): 467.
[http://dx.doi.org/10.3390/cells8050467] [PMID: 31100966]
[49]
Wu XF, Ouyang ZJ, Feng LL, et al. Suppression of NF-κB signaling and NLRP3 inflammasome activation in macrophages is responsible for the amelioration of experimental murine colitis by the natural compound fraxinellone. Toxicol Appl Pharmacol 2014; 281(1): 146-56.
[http://dx.doi.org/10.1016/j.taap.2014.10.002] [PMID: 25448682]
[50]
Heng F, Si C. Research of extracelluar vesicles derived from mesenchymal stem cells in inflamma-tory bowel disease. Chin J Gastroenterol Hepatol 2020; 29(9): 5.
[http://dx.doi.org/10.3969/j.issn.1006-5709.2020.09.002.]
[51]
An JH, Li Q, Ryu MO, et al. TSG-6 in extracellular vesicles from canine mesenchymal stem/stromal is a major factor in relieving DSS-induced colitis. PLoS One 2020; 15(2)e0220756
[http://dx.doi.org/10.1371/journal.pone.0220756] [PMID: 32040478]
[52]
Rovedatti L, Kudo T, Biancheri P, et al. Differential regulation of interleukin 17 and interferon gamma production in inflammatory bowel disease. Gut 2009; 58(12): 1629-36.
[http://dx.doi.org/10.1136/gut.2009.182170] [PMID: 19740775]
[53]
Chen Q, Duan X, Xu M, et al. BMSC-EVs regulate Th17 cell differentiation in UC via H3K27me3. Mol Immunol 2020; 118: 191-200.
[http://dx.doi.org/10.1016/j.molimm.2019.12.019] [PMID: 31896495]
[54]
Du YM, Zhuansun YX, Chen R, Lin L, Lin Y, Li JG. Mesenchymal stem cell exosomes promote immunosuppression of regulatory T cells in asthma. Exp Cell Res 2018; 363(1): 114-20.
[http://dx.doi.org/10.1016/j.yexcr.2017.12.021] [PMID: 29277503]
[55]
Liu X, Heng F, Qing T, Ling T, Zhang L, Zuo DM. Intravenous administration of mesenchymal stem cells overexpressing CXCR4 protects against experimental colitis in rats. World Chin J Digestology 2016; (8): 8.
[http://dx.doi.org/10.11569/wcjd.v24.i8.1233]
[56]
Dong S. Effects and Molecular Mechanism of Optimized BMMSCs Alleviating Inflammatory Injuries of Intestinal Epithelial Cells. Tianjin Medical University 2020.
[http://dx.doi.org/10.27366/d.cnki.gtyku.2020.000046]
[57]
Kan W, Zhi J A. Keith, Webster, Jinghai, Chen, Hengxun, Hu. Enhanced Cardioprotection by Human Endometrium Mesenchymal Stem Cells Driven by Exosomal MicroRNA-21. Stem Cells Transl Med 2017.
[http://dx.doi.org/10.5966/sctm.2015-0386]
[58]
Yang J, Liu X-X, Fan H, et al. Extracellular Vesicles Derived from Bone Marrow Mesenchymal Stem Cells Protect against Experimental Colitis via Attenuating Colon Inflammation, Oxidative Stress and Apoptosis. PLoS One 2015; 10(10)e0140551
[http://dx.doi.org/10.1371/journal.pone.0140551] [PMID: 26469068]
[59]
Eirin A, Zhu XY, Puranik AS, et al. Comparative proteomic analysis of extracellular vesicles isolated from porcine adipose tissue-derived mesenchymal stem/stromal cells. Sci Rep 2016; 6: 36120.
[http://dx.doi.org/10.1038/srep36120] [PMID: 27786293]
[60]
Liu A, Zhang X, He H, et al. Therapeutic potential of mesenchymal stem/stromal cell-derived secretome and vesicles for lung injury and disease. Expert Opin Biol Ther 2020; 20(2): 125-40.
[http://dx.doi.org/10.1080/14712598.2020.1689954] [PMID: 31701782]
[61]
Tsiapalis D, O’Driscoll L. Mesenchymal Stem Cell Derived Extracellular Vesicles for Tissue Engineering and Regenerative Medicine Applications. Cells 2020; 9(4): 991.
[http://dx.doi.org/10.3390/cells9040991] [PMID: 32316248]
[62]
Zhang J, Gong JF, Zhang W, Zhu WM, Li JS. Effects of transplanted bone marrow mesenchymal stem cells on the irradiated intestine of mice. J Biomed Sci 2008; 15(5): 585-94.
[http://dx.doi.org/10.1007/s11373-008-9256-9] [PMID: 18763056]
[63]
Ren G, Zhao X, Zhang L, et al. Inflammatory cytokine-induced intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in mesenchymal stem cells are critical for immunosuppression. J Immunol 2010; 184(5): 2321-8.
[http://dx.doi.org/10.4049/jimmunol.0902023] [PMID: 20130212]
[64]
Ping J. The efficacy and safety of Mesenchymal Stromal Cells for the treatment of Inflammatory bowel disease: A Meta-Analysis. Fujian Medical University 2019.
[http://dx.doi.org/10.27020/d.cnki.gfjyu.2019.000757]
[65]
Corcione A, Benvenuto F, Ferretti E, et al. Human mesenchymal stem cells modulate B-cell functions. Blood 2006; 107(1): 367-72.
[http://dx.doi.org/10.1182/blood-2005-07-2657] [PMID: 16141348]
[66]
Salama P, Platell C. Colorectal cancer stem cells. World Chin J Digestology 2009; 79(10): 697-702.
[http://dx.doi.org/10.1111/j.1445-2197.2009.05054.x] [PMID: 19878163]
[67]
Andoh A, Bamba S, Brittan M, Fujiyama Y, Wright NA. Role of intestinal subepithelial myofibroblasts in inflammation and regenerative response in the gut. Pharmacol Ther 2007; 114(1): 94-106.
[http://dx.doi.org/10.1016/j.pharmthera.2006.12.004] [PMID: 17328956]
[68]
Alison MR, Lovell MJ, Direkze NC, Wright NA, Poulsom R. Stem cell plasticity and tumour formation. Eur J Cancer 2006; 42(9): 1247-56.
[http://dx.doi.org/10.1016/j.ejca.2006.01.034] [PMID: 16632345]
[69]
Fontani F, Marcucci T, Picariello L, Tonelli F, Vincenzini MT, Iantomasi T. Redox regulation of MMP-3/TIMP-1 ratio in intestinal myofibroblasts: Effect of N-acetylcysteine and curcumin. Exp Cell Res 2014; 323(1): 77-86.
[http://dx.doi.org/10.1016/j.yexcr.2014.02.019] [PMID: 24583398]
[70]
Ma S, Xie N, Li W, Yuan B, Ying W. Immunobiology of mesenchymal stem cells. Cell Death Differ 2013.
[PMID: 24185619]
[71]
Yabana T, Arimura Y, Tanaka H, et al. Enhancing epithelial engraftment of rat mesenchymal stem cells restores epithelial barrier integrity. J Pathol 2009; 218(3): 350-9.
[http://dx.doi.org/10.1002/path.2535] [PMID: 19291714]
[72]
Goessling W, North TE, Loewer S, et al. Genetic interaction of PGE2 and Wnt signaling regulates developmental specification of stem cells and regeneration. Cell 2009; 136(6): 1136-47.
[http://dx.doi.org/10.1016/j.cell.2009.01.015] [PMID: 19303855]
[73]
Bettess MD, Dubois N, Murphy MJ, et al. c-Myc is required for the formation of intestinal crypts but dispensable for homeostasis of the adult intestinal epithelium. Mol Cell Biol 2005; 25(17): 7868-78.
[http://dx.doi.org/10.1128/MCB.25.17.7868-7878.2005] [PMID: 16107730]
[74]
Xu W, Chen J, Liu X, Li H, Qi X, Guo X. Autologous bone marrow stromal cell transplantation as a treatment for acute radiation enteritis induced by a moderate dose of radiation in dogs. Transl Res 2016; 171: 38-51.
[http://dx.doi.org/10.1016/j.trsl.2015.12.010] [PMID: 26763584]
[75]
Yin M, Shen Z, Yang L, Zheng W, Song H. Protective effects of CXCR3/HO 1 gene modified BMMSCs on damaged intestinal epithelial cells: Role of the p38 MAPK signaling pathway. Int J Mol Med 2019; 43(5): 2086-102.
[http://dx.doi.org/10.3892/ijmm.2019.4120] [PMID: 30864680]
[76]
Xie M, Li X, Lei L. Application and prospect of mesenchymal stem cells in treatment of inflammatory bowel disease. Chinese Journal of Cell and Stem Cell 2019; 9(4): 6.
[77]
Heidari M, Pouya S, Baghaei K, et al. The immunomodulatory effects of adipose-derived mesenchymal stem cells and mesenchymal stem cells-conditioned medium in chronic colitis. J Cell Physiol 2018; 233(11): 8754-66.
[http://dx.doi.org/10.1002/jcp.26765] [PMID: 29797577]
[78]
Yang S. Mechanism and application prospect of exosomes derived from mesenchymal stem cells in the treatment of inflammatory bowel disease. Chinese Journal of Cell and Stem Cell 2021; 10: 368-72.
[79]
Weis VG, Deal AC, Mekky G, Clouse C, Atala A. Human placental-derived stem cell therapy ameliorates experimental necrotizing enterocolitis. AJP Gastrointestinal and Liver Physiology 2021; p. 760.
[80]
Ruo W, Yao Q, Chen W, et al. Stem cell therapy for Crohn’s disease: systematic review and meta-analysis of preclinical and clinical studies. Stem Cell Res Ther 2021; 12(1)
[http://dx.doi.org/10.1186/S13287-021-02533-0]

Rights & Permissions Print Cite
Article Metrics
12
© 2024 Bentham Science Publishers | Privacy Policy